Acutaas Chemicals Limited (ACUTAAS): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Acutaas Chemicals Limited, explained in plain English.

• ▪Acutaas Chemicals Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪ACUTAAS closed at ₹3,976.70 on 29 October 2026.
• ▪Over the past year the shares are up 135.4%, trading between ₹1,570.00 and ₹4,032.20.
• ▪Reported fundamentals show return on equity of 26.11%, a net margin of 27.91%, debt to equity of 0.79.
• ▪Our transparent MaxGrade checklist scores it A (88/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 46.77% with a maximum drawdown of -17.53% and a beta of 0.8 against NIFTY 50.
• ▪Recent coverage: Acutaas Chemicals among 5 stocks hitting 52-week highs; rallied up to 18% in a month
• ▪Recent coverage: Acutaas Chemicals rallies 13%; hits record high on strong Q2 results

Other Pharma & Healthcare companies: Abbott India, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma, Biocon

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.